دورية أكاديمية
Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management
| العنوان: | Immunosenescence, gut dysbiosis, and chronic kidney disease: Interplay and implications for clinical management |
|---|---|
| المؤلفون: | Tao Han Lee, Jia-Jin Chen, Chao-Yi Wu, Ting-Yun Lin, Szu-Chun Hung, Huang-Yu Yang |
| المصدر: | Biomedical Journal, Vol 47, Iss 2, Pp 100638- (2024) |
| بيانات النشر: | Elsevier, 2024. |
| سنة النشر: | 2024 |
| المجموعة: | LCC:Medicine (General) LCC:Biology (General) |
| مصطلحات موضوعية: | immunosenescence, inflamm-aging, CKD, gut dysbiosis, Medicine (General), R5-920, Biology (General), QH301-705.5 |
| الوصف: | Immunosenescence refers to the immune system changes observed in individuals over 50 years old, characterized by diminished immune response and chronic inflammation. Recent investigations have highlighted similar immune alterations in patients with reduced kidney function. The immune system and kidney function have been found to be closely interconnected. Studies have shown that as kidney function declines, both innate and adaptive immunity are affected. Chronic kidney disease (CKD) patients exhibit decreased levels of naive and regular T cells, as well as naive and memory B cells, while memory T cell counts increase. Furthermore, research suggests that CKD and end-stage kidney disease (ESKD) patients experience early thymic dysfunction and heightened homeostatic proliferation of naive T cells. In addition to reduced thymic T cell production, CKD patients display shorter telomeres in both CD4+ and CD8+ T cells.Declining kidney function induces uremic conditions, which alter the intestinal metabolic environment and promote pathogen overgrowth while reducing diversity. This dysbiosis-driven imbalance in the gut microbiota can result in elevated production of uremic toxins, which, in turn, enter the systemic circulation due to compromised gut barrier function under uremic conditions. The accumulation of gut-derived uremic toxins exacerbates local and systemic kidney inflammation. Immune-mediated kidney damage occurs due to the activation of immune cells in the intestine as a consequence of dysbiosis, leading to the production of cytokines and soluble urokinase-type plasminogen activator receptor (suPAR), thereby contributing to kidney inflammation.In this review, we delve into the fundamental mechanisms of immunosenescence in CKD, encompassing alterations in adaptive immunity, gut dysbiosis, and an overview of the clinical findings pertaining to immunosenescence. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2319-4170 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S2319417023000756; https://doaj.org/toc/2319-4170 |
| DOI: | 10.1016/j.bj.2023.100638 |
| URL الوصول: | https://doaj.org/article/12b5aed08bee4768b0272ab1c6cfb90e |
| رقم الأكسشن: | edsdoj.12b5aed08bee4768b0272ab1c6cfb90e |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 23194170 |
|---|---|
| DOI: | 10.1016/j.bj.2023.100638 |